Related references
Note: Only part of the references are listed.Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States
Megan H. Noe et al.
JAMA DERMATOLOGY (2022)
Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings?
Chapagain Pukar et al.
CLINICAL CASE REPORTS (2021)
Tildrakizumab for treatment of refractory pyoderma gangrenosum of the penis and polymyalgia rheumatica: Killing two birds with one stone
Jared Marc John et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2020)
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review
April W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations
Egidio Freitas et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study
Kenshi Yamasaki et al.
JOURNAL OF DERMATOLOGY (2020)
Pyoderma gangrenosum
Emanual Maverakis et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Pyoderma gangrenosum treated with secukinumab: A case report
Meghan L. McPhie et al.
SAGE OPEN MEDICAL CASE REPORTS (2020)
Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes
Roman Saternus et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)
Are neutrophilic dermatoses autoinflammatory disorders?
T. K. Satoh et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Neutrophilic dermatoses Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses
Hovik J. Ashchyan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Pros and cons of biological therapy in psoriasis
C. Solovan et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Effective Strategies for the Management of Pyoderma Gangrenosum: A Comprehensive Review
Forum Patel et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Canakinumab in adults with steroid-refractory pyoderma gangrenosum
A. G. A. Kolios et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
Anthony D. Ormerod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
Anthony D. Ormerod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Rare association of pyoderma gangrenosum and palmoplantar pustulosis: A case report and review of the previous works
Mikio Ohtsuka et al.
JOURNAL OF DERMATOLOGY (2014)
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
David A. Martin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab
Ari M. Goldminz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Differential in situ expression of IL-17 in skin diseases
Mattias Fischer-Stabauer et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2012)
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
M. Brenner et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Share Paper
